InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Staab Thomas R II, 首席财务官. Director active across 3 companies, notably Tenax Therapeutics, INC.. Cumulatively, 15 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €6k. History available since 11 January 2022. The latest transaction was filed on 11 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Staab Thomas R II
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
10,000 股0Common StockSEC:0001193125-26-221926:0
5,500 股@ US$2.6525.7% 占其流量Common StockSEC:0001193125-26-116117:0
1,076 股@ US$11.3213.2% 占其流量Common StockSEC:0001193125-26-061464:0
1,826 股@ US$11.5723.3% 占其流量Common StockSEC:0001193125-26-011796:0
12,766 股0Common StockSEC:0000950170-25-024336:0
1,839 股@ US$8.2540.0% 占其流量Common StockSEC:0000950170-25-015541:0
3,500 股@ US$2.6523.1% 占其流量Common StockSEC:0000950170-24-095487:0
1,853 股@ US$4.4320.3% 占其流量Common StockSEC:0000950170-24-055774:0
6,656 股0Common StockSEC:0000899243-23-001798:0
2,025 股@ US$3.16216.6% 占其流量Common StockSEC:0000899243-22-037965:0
标准退出：2023年3月6日 (T+90)
15,000 股0Common StockSEC:0000899243-22-001924:0
4,823 股Common StockSEC:0001127602-16-037574:0
2,500 股Common StockSEC:0001127602-16-037469:0
12,500 股Common StockSEC:0001127602-16-037469:1
1,676 股Common StockSEC:0001127602-16-035651:0
15 条申报中的 15 条
About Staab Thomas R II
Thomas R. Staab II is the Chief Financial Officer at Tenax Therapeutics, Inc. and LENSAR, Inc. He oversees the financial and strategic operations of both companies. His role is crucial in ensuring their financial health and supporting their growth in the market.
